Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Association of Gestational Free and Total Triiodothyronine With Gestational Hypertension, Preeclampsia, Preterm Birth, and Birth Weight: An Individual Participant Data Meta-Analysis Publisher Pubmed



Derakhshan A1, 2 ; Mannisto T3 ; Chen L4 ; Osinga JAJ1, 2 ; Ashoor G5 ; Lu X4 ; Bliddal S6, 7 ; Tao FB8, 9 ; Brown SJ10 ; Vaidya B11 ; Hattersley AT12 ; Itoh S13 ; Popova PV14, 15 ; Aminorroaya A16 Show All Authors
Authors
  1. Derakhshan A1, 2
  2. Mannisto T3
  3. Chen L4
  4. Osinga JAJ1, 2
  5. Ashoor G5
  6. Lu X4
  7. Bliddal S6, 7
  8. Tao FB8, 9
  9. Brown SJ10
  10. Vaidya B11
  11. Hattersley AT12
  12. Itoh S13
  13. Popova PV14, 15
  14. Aminorroaya A16
  15. Kishi R13
  16. Kianpour M16
  17. Vasukova EA14
  18. Lopezbermejo A17, 18
  19. Oken E19
  20. Chatzi L20
  21. Vafeiadi M21
  22. Bramer WM22
  23. Bassols J23
  24. Lertxundi A24, 25, 26
  25. Fernandezsomoano A24, 27, 28
  26. Carrasco P29, 30
  27. Auvinen J31
  28. Huang K32, 33
  29. Feldtrasmussen U6, 7
  30. Grineva EN14
  31. Alexander EK34
  32. Pearce EN35
  33. Chaker L1, 2
  34. Walsh JP10, 36
  35. Peeters RP1, 2
  36. Guxens M24, 37, 38, 39
  37. Suvanto E40
  38. Nicolaides KH41
  39. Korevaar TIM1, 2
Show Affiliations
Authors Affiliations
  1. 1. Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, 3015 GD, Netherlands
  2. 2. Academic Center for Thyroid Diseases, Erasmus University Medical Center, Rotterdam, 3015 GD, Netherlands
  3. 3. Northern Finland Laboratory Center Nordlab and Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, 90570, Finland
  4. 4. Department of Endocrinology, Rui’an Center, The Chinese, American Research Institute for Diabetic Complications, Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, China
  5. 5. Harris Birthright Research Center for Fetal Medicine, King’s College Hospital, London, SE5 9RS, United Kingdom
  6. 6. Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital, Rigshospitalet, Copenhagen, 2100, Denmark
  7. 7. Department of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, 1172, Denmark
  8. 8. Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Anhui, Hefei, 230032, China
  9. 9. Anhui Provincial Key Laboratory of Population Health & Aristogenics, Anhui, Hefei, 230032, China
  10. 10. Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Perth, 6009, WA, Australia
  11. 11. Department of Endocrinology, Royal Devon University Hospital NHS Foundation Trust, University of Exeter Medical School, Exeter, EX1 2LU, United Kingdom
  12. 12. Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, EX1 2LU, United Kingdom
  13. 13. Center for Environmental and Health Sciences, Hokkaido University, Hokkaido, Sapporo, 060-0808, Japan
  14. 14. World-Class Research Center for Personalized Medicine, Institute of Endocrinology, Almazov National Medical Research Centre, Saint Petersburg, 197341, Russian Federation
  15. 15. Department of Internal Diseases and Endocrinology, St.Petersburg Pavlov State Medical University, Saint Petersburg, 197341, Russian Federation
  16. 16. Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, 81745-33871, Iran
  17. 17. Pediatric Endocrinology Research Group, Girona Biomedical Research Institute (IDIBGI), Dr. Josep Trueta Hospital, Girona, 17007, Spain
  18. 18. Departament de Ciencies Mediques, Universitat de Girona, Girona, 17007, Spain
  19. 19. Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School, Boston, 02215, MA, United States
  20. 20. Department of Population and Public Health Sciences UoSC, Keck School of Medicine, Los Angeles, 90033, CA, United States
  21. 21. Department of Social Medicine, School of Medicine, University of Crete, Heraklion, Crete, 700 13, Greece
  22. 22. Medical Library, Erasmus University Medical Centre, Rotterdam, 3015, Netherlands
  23. 23. Maternal-Fetal Metabolic Research Group, Girona Biomedical Research Institute (IDIBGI), Dr. Josep Trueta Hospital, Girona, 17007, Spain
  24. 24. Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, 28029, Spain
  25. 25. Department of Preventive Medicine and Public Health, University of Basque Country, Leioa, 48940, Spain
  26. 26. BIODONOSTIA Health Research Institute, San Sebastian, 20014, Spain
  27. 27. Unit of Molecular Cancer Epidemiology, University Institute of Oncology of the Principality of Asturias (IUOPA), Department of Medicine, University of Oviedo, Oviedo, Asturias, 33006, Spain
  28. 28. Institute of Health Research of the Principality of Asturias (ISPA), Oviedo, 33006, Spain
  29. 29. Epidemiology and Environmental Health Joint Research Unit, FISABIO−Universitat Jaume I−Universitat de Valencia, Valencia, 46020, Spain
  30. 30. Department of Medicine, Universitat Jaume I, Castellon de la Plana, 12071, Spain
  31. 31. Medical Research Center Oulu, Oulu University Hospital, Center for Life Course Health Research, University of Oulu, Oulu, 90570, Finland
  32. 32. Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Anhui, 230032, China
  33. 33. Scientific Research Center in Preventive Medicine, School of Public Health, Anhui Medical University, Anhui, 230032, China
  34. 34. Division of Endocrinology, Hypertension and Diabetes, Brigham and Women’s Hospital, Harvard Medical School, Boston, 02215, MA, United States
  35. 35. Section of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine, Boston, 02215, MA, United States
  36. 36. Medical School, University of Western Australia, Crawley, 6009, WA, Australia
  37. 37. ISGlobal, Barcelona, 08003, Spain
  38. 38. Pompeu Fabra University, Barcelona, 08002, Spain
  39. 39. Department of Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Centre, Sophia Children’s Hospital, Rotterdam, 3012, Netherlands
  40. 40. Department of Obstetrics and Gynecology, Medical Research Center Oulu, University of Oulu, Oulu, 90570, Finland
  41. 41. Department of Women and Children’s Health, Faculty of Life Sciences, Medicine King’s College London, London, WC2R 2LS, United Kingdom

Source: Journal of Clinical Endocrinology and Metabolism Published:2024


Abstract

Context: Triiodothyronine (T3) is the bioactive form of thyroid hormone. In contrast to thyroid-stimulating hormone and free thyroxine, we lack knowledge on the association of gestational T3 with adverse obstetric outcomes. Objective: To investigate the associaiton of gestational free or total T3 (FT3 or TT3) with adverse obstetric outcomes. Methods: We collected individual participant data from prospective cohort studies on gestational FT3 or TT3, adverse obstetric outcomes (preeclampsia, gestational hypertension, preterm birth and very preterm birth, small for gestational age [SGA], and large for gestational age [LGA]), and potential confounders. We used mixed-effects regression models adjusting for potential confounders. Results: The final study population comprised 33 118 mother–child pairs of which 27 331 had data on FT3 and 16 164 on TT3. There was a U-shaped association of FT3 with preeclampsia (P = .0069) and a J-shaped association with the risk of gestational hypertension (P = .029). Higher TT3 was associated with a higher risk of gestational hypertension (OR per SD of TT3 1.20, 95% CI 1.08 to 1.33; P = .0007). A lower TT3 but not FT3 was associated with a higher risk of very preterm birth (OR 0.72, 95% CI 0.55 to 0.94; P = .018). TT3 but not FT3 was positively associated with birth weight (mean difference per 1 SD increase in TT3 12.8, 95% CI 6.5 to 19.1 g, P < .0001) but there was no association with SGA or LGA. Conclusion: This study provides new insights on the association of gestational FT3 and TT3 with major adverse pregnancy outcomes that form the basis for future studies required to elucidate the effects of thyroid function on pregnancy outcomes. Based on the current study, routine FT3 or TT3 measurements for the assessment of thyroid function during pregnancy do not seem to be of added value in the risk assessment for adverse outcomes. © The Author(s) 2023.
Experts (# of related papers)
Other Related Docs
16. Guideline for the Treatment of Hypothyroidism in Prematurity, International Journal of Preventive Medicine (2021)
27. Congenital Hypothyroidism; Is There Any Familial Component?, Journal of Isfahan Medical School (2009)